Japan clearance for mogamulizumab in PTCL/CTCL
This article was originally published in Scrip
Executive Summary
Japan's ministry of health, labour and welfare has approved Kyowa Hakko Kirin's antibody Poteligeo (mogamulizumab) for two new orphan lymphoma indications following a regulatory filing last July.